Amarin Corp Plc (AMRN)

[VuBru]

FFS - Don't know about their having unblinded info, but not impossible - I worked with a private pharma company once who had a blinded trial in the DMC phase, and a scientist who was supposed to still be blind told me off the record that the results for primary outcomes didn't look good. Whether or not this is occurring with Amarin, the company has every incentive to slow walk a stop at 80%. The longer they wait, the more events they have in the final locked dataset, and the closer to 100% they will be. I really doubt a stop at what amounts to 90% of planned events really will be seen with a jaundiced eye by anyone. Questions raised with prior trials halted early have been with trials stopped much earlier in the study.